# 1. Financial Performance ## A. Key Figures * **Revenue:** **$65.7M** Q3 (+7.1% YoY cc, +1.2% QoQ) · **₹588 Cr** (+10.7% YoY, +2.4% QoQ) * **Total Income:** **₹604 Cr** Q3 (+9% YoY, +4% QoQ) · **₹1,711 Cr** 9M (+8% YoY) * EBITDA: ₹123 Cr Q3 (20.4% margin) · ₹367 Cr 9M (20.6% margin) * **PAT:** **₹40.3 Cr** Q3 · **₹152 Cr** 9M; **Adjusted PAT:** **₹208 Cr** 9M (+7% YoY) * **Liquidity:** **₹1,520 Cr** cash and equivalents * **Return Metrics:** **ROCE 22%**, **ROE 12%** ## B. Revenue Growth * **Steady Growth Trajectory:** Revenue expanded both sequentially and annually, driven by resilient demand in digital and AI-led programs despite sector-wide selectivity. * **Growth Quality:** Q3 dollar growth was partially muted by normalization from an extra billing cycle in Q2, indicating underlying operational consistency. * **Strategic Momentum:** Continued investment in AI is translating into sustained execution, with constant currency performance within guided ranges. ## C. Profitability Trends * **Margin Recovery:** EBITDA margin improved to 21.0%, reflecting operating leverage and GBS segment strength, despite forex headwinds and fewer working days. * **Adjusted Earnings Growth:** Adjusted PAT increased year-on-year to ₹208 Cr, excluding one-time wage code and acquisition-related costs, signaling core profitability resilience. * **Gross Margin Uptick:** Margins have improved over the past two quarters, supported by favorable forex and pricing discipline, though pressure remains from mix and macro factors. ## D. Balance Sheet * **Strong Liquidity Position:** Robust cash balance of ₹1,520 Cr provides flexibility for strategic investments, despite rising working capital-linked debt. * **Debt Transparency Gap:** No timeline provided for debt repayment or future capital plans, drawing investor concern over balance sheet optimization. * **Healthy Short-Term Health:** High current ratio and export-backed preferential borrowings support liquidity management despite elevated receivables. ## E. Cash Flow * **DSO Elevated but Managed:** Days Sales Outstanding rose to 92 days from 87, though collections are stabilizing; target set to reduce to 85 days. * **Efficient Receivables Funding:** Receivables financed via low-cost export-linked borrowings at **6–7%**, enhancing treasury efficiency and cash flow stability. --- # 2. Segment & Vertical Performance ## A. Key Figures * **GBS & AI Services Revenue Growth:** **~50%** QoQ * **Happiest Health Clinics:** **6** operational · **26** planned within 12 months ## B. PDES & IMSS * **Core Engineering Strength:** PDES remains largest unit, with AI now embedded in core product engineering and platform modernization initiatives. * **Infrastructure Modernization Demand:** IMSS seeing sustained traction in AI-enabled infrastructure management, cloud optimization, and automation-driven efficiency programs. ## C. GBS & AI Services * **AI Acceleration:** GBS and AI services delivered nearly 50% QoQ revenue growth as clients shift from AI pilots to full-scale production deployments. * **Profitability Achieved:** Business turned profitable this quarter on improved execution, reuse, and focus on delivering measurable AI-driven business outcomes. * **Growth Momentum:** Sequential growth in GBS sustained, with intent to carry momentum into next quarter and fiscal year. ## D. BFSI & Healthcare * **Top-Performing Verticals:** BFSI and Healthcare led growth, with Healthcare showing strong momentum over three quarters across geographies and client segments. * **Healthcare Expansion Drivers:** Growth fueled by ramp-up at a major pharma client, scaling of a medical supplies marketplace, and AI-enabled bioinformatics collaborations with research institutions. * **Happiest Health Vision:** Aiming to build a first-of-its-kind integrated healthcare and wellness model in India via specialty clinics outside traditional hospital settings. * **Q4 Growth Outlook:** BFSI expected to see uplift from Arttha license revenues; Healthcare to grow via ramp-up of a major AI/GenAI-powered diagnostic platform. ## E. Hi-Tech & Retail * **Platform Repeatability:** AI-led, platform-driven solutions scaling across premium retailers (Australia/NZ), U.S. healthcare BPOs, and academic institutions (Asia/India). * **Retail Contraction:** Retail vertical declined after nine consecutive quarters of growth, primarily due to furloughs at a large customer (~70,000 impact) and project wind-down. * **Q4 Recovery Expected:** Revenue recovery anticipated in Q4 from resumption of follow-on work with major beverage manufacturer post automation project completion. --- # 3. Deal Wins & Pipeline ## A. Key Figures * **Minimum TCV for Press Releases:** **$250 Mn**, with deals reaching **$300–400 Mn** for strategic consulting or discovery work * **New Customer Additions:** **13 new logos** in first half of FY '27, highest recorded, driven by NN sales investments * **GenAI Use Cases in Production:** **32** prototype-to-production transitions, several now scaling ## B. Large Deal Momentum * **Strong Pipeline Growth:** Significant increase in large deal pipeline and wins, with positive momentum across verticals and **ACV/GBS metrics signaling sustained revenue visibility**. * **Strategic Long-Term Shift:** Rising prevalence of **3–4-year tenure engagements**, including flagship projects like a QA testing center of excellence in Muscat, reflects deeper, high-impact client partnerships. * **Public Sector Interest:** A leading state government has requested a **memorandum of understanding** for a long-term AI partnership, underscoring strategic credibility. ## C. AI-Led Engagements * **Inflection Point in AI Adoption:** Q3 marks a turning point as enterprises move from exploration to execution, with **growing ROI confidence in Generative and Agentic AI** driving deal flow. * **Diversified AI Deal Models:** Engagement structures span **license-based, fixed-price, outcome-based, and effort-based** models, enabling flexibility and scalability across client needs. * **AI Budget Maturation:** Enterprise funding has evolved from ad-hoc spending to **1–3-year strategic roadmaps**, with AI now embedded in core budgets, particularly in hi-tech and health tech. * **Converged Digital & AI Demand:** Recent multimillion-dollar edu-tech deals include **close to $1 Mn in AI/GenAI layering**, demonstrating tight integration of digital transformation and AI initiatives. ## D. New Customer Additions * **Record New Logo Acquisition:** Surge in new customer wins, including a **start-up in the agentic AI platform space**, highlights expanded market reach and **upside potential for future scaling**. * **Broader Market Appeal:** Hybrid AI solutions are attracting **private equity firms and portfolio companies**, signaling diversification beyond traditional enterprise clients. --- # 4. Headcount & Utilization ## A. Key Figures * **Headcount:** **6,548** employees (end of quarter) * **Utilization Rate:** **82%** (Q3, highest in recent times) (+200 bps from prior) ## B. Employee Growth * **Scaled Workforce:** Headcount expansion supports growing delivery capacity, underpinned by a robust offshore delivery model. ## C. Utilization Rate * **Peak Efficiency:** Utilization reached a multi-quarter high, driven by stronger deployment, execution discipline, and scaling of **AI-led engagements**. * **Improvement Trajectory:** Operational leverage improving sequentially, with active initiatives in place to push utilization higher. --- # 5. Product & Platform Progress ## A. Key Figures * IP-led Sales: 10.4% of revenue (higher gross margins) ## B. AI Delivery Platform * **Strategic Inflection Point:** Company has launched *AI First, Agile Always* as 11th transformation, marking a structural shift in delivery and value creation, now yielding visible, measurable results. * **Platform-Led Execution:** AI Services Delivery Platform enables shift from pilots to **production-grade, reusable solutions**, accelerating time-to-market and driving operating leverage across verticals. * **Agentic AI Traction:** Hybrid model combining coding agents with human developers is gaining adoption for **cost-efficient, low-risk modernization** of legacy systems and tech debt reduction. * **Scalable AI Solutions:** 32 existing GenAI use cases targeted for scale; platform now supports AI assistants, domain copilots, and AI-powered operations across IT, sales, and support. * **Leadership Commitment:** Ashok Soota is personally leading the AI transformation with 11 strategic programs, reaffirming long-term commitment despite stake sale rumors. ## C. Vertical-Specific Platforms * **IP-Led Growth Model:** Platforms like *Arttha*, *Insurance in a Box*, and *multi-omics* deliver higher margins and are being packaged for repeatability, with **education and healthcare** emerging as new verticals. * **Insurance & Healthcare Momentum:** Agentic AI embedded into *Insurance in a Box*; multi-omics platform is market-ready with active go-to-market, while a second healthcare platform is in ideation. * **Education Sector Opportunity:** Pilots underway with universities in India and Southeast Asia to address data silos, retention, and recruitment via **AI-powered, platform-based solutions**. ## D. AI-Infused Operations Platforms * **ELLIPSE & SecAiGenie Live:** AIOps-enhanced ELLIPSE improves infrastructure management efficiency, while SecAiGenie delivers AI-driven threat detection and MDR with measurable service and cost benefits. * **Beyond Traditional Services:** Both platforms represent a shift to **AI-driven operations**, differentiating offerings in managed and shared services with tangible performance gains. ## E. Monetization & Strategy * **Subscription Expansion:** Arttha remains the sole SaaS/subscription offering today, but additional subscription-based models are planned, leveraging proprietary platforms. * **AI as Growth Catalyst:** AI is the strategic priority for accelerating growth beyond current levels, built on a foundation of digital leadership in cloud, cybersecurity, and automation. --- # 6. Client & Demand Risks ## A. Startup Customer Risk * **AI Turbulence as Opportunity:** Recent AI-driven market volatility is viewed as strategic validation, reinforcing Happiest Minds’ AI First approach rather than posing a threat. * **Conditional Revenue Resumption:** Engagement with the U.S. startup may resume post-product validation, though exposure to early-stage clients continues to carry inherent execution risk. ## B. EdTech Exposure * **EdTech Downturn:** The edtech vertical has weakened significantly, falling to third-largest due to sustained pressure in the U.S. higher education segment. ## C. Hi-Tech Pricing Pressure * **AI-Driven Demand Focus:** Client conversations are now centered on embedding AI into core operations, with strong interest in **GenAI and Agentic AI** for workflow automation and productivity gains. * **Selective but Intentional Spend:** Demand remains cautious but purposeful, prioritizing initiatives with clear business cases and measurable outcomes. * **Hi-Tech Revenue Decline:** Q-o-Q drop in hi-tech revenue driven by project completion for a U.S. startup and contract end with the **Airport Authority of India**. * **Pricing and Productivity Dynamics:** Clients are pushing for lower costs and higher output, but the company is countering through **proactive deployment of productivity tools**, maintaining quality and throughput without triggering broad ramp-downs. * **CTO Support for Tool Adoption:** CTOs affirm that productivity enhancements should not lead to team reductions, reinforcing the company’s stance in managed and fixed-price engagements. * **Industry-Wide Headwinds:** Despite internal progress, company performance has been impacted by broad-based downturns across the IT sector. ## D. Industrial Sector * **Stable Portfolio with Modest Industrial Uptick:** Industrial sector showed slight improvement, while other verticals remained largely stable. --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth Guidance:** **>10%** full-year outlook reaffirmed, with potential to **significantly increase guidance** by Q4 * **AI/GenAI Team Size Target:** **1,000 members** by end of FY'27 * **Happiest Health IPO Timeline:** Expected **~6 years from now (FY'30)**, with current revenues described as **"rather sad"** ## B. Strategic Growth & Investment * **AI-Led Expansion:** Growth strategy centered on scaling AI/GenAI capabilities and deepening client engagements, with team size set to reach **1,000 by FY'27** under financial discipline. * **New Trajectory Signal:** Company poised for strategic shift, with major announcements expected at end of Q4 indicating **step-up in growth momentum**. ## C. Vertical Performance & Outlook * **Tech Sector Rebound Expected:** Leadership anticipates reversal of industry downturn by **FY'27**, led by North America and AI-enhanced edtech solutions; edtech risks seen as largely resolved. * **Near-Term Revenue Pipeline:** Hi-tech, RCL, and GBS verticals show improving funnel maturity, with **multiple deals in advanced stages** set to contribute from Q4 onward. ## D. Margin & Capital Strategy * **Customer-Centric Pricing:** Productivity gains will be fully passed through to clients, prioritizing market share and stickiness over margin retention. * **Capital Discipline:** Investment levels to remain stable; focus shifts to optimizing returns on existing initiatives rather than new outlays.